in 45% of patients there is symptomatic resolution within 20 days
in 25% of patients symptoms may persist for two months
study evidence revealed that psychiatric and neurological disorders persisted for more than two months in 30% of patients - however a causal link with mefloquine prophylaxis was not firmly established
Reference:
Prescribers' Journal (1999), 39 (3), 154-63.
Schlagenhauf P et al. The position of mefloquine as a 21st century malaria chemoprophylaxis.Malar J. 2010 Dec 9;9:357.
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.